Note 6 - Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2014

Disclosure Text Block [Abstract]

Schedule of Finite-Lived Intangible Assets [Table Text Block]

	Bertilimumab iCo			NanomAbs Yissum			Human Antibodies Kadouche			Anti-ferritin Antibody MabLife			Total
Balance as of December 31, 2012	$	2,254		$	613		$	615		$	414		$	3,896
Additions		—			—			—			—			—
Amortization		(167	)		(46	)		(47	)		(29	)		(289	)
Balance, December 31, 2013	$	2,087		$	567		$	568		$	385		$	3,607
Additions (see Note 8 (5))		—			—			—			111			111
Amortization		(42	)		(11	)		(12	)		(9	)		(74	)
Balance, March 31, 2014	$	2,045		$	556		$	556		$	487		$	3,644

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Period Ending		Amount
2014	$	229
2015		305
2016		305
2017		305
2018 and thereafter		2,500
Total	$	3,644